 |
 |
|
|
RESÚMENES MARZO 2008 |
Schizophrenia-Psychotic Disorders & Antipsychotics
(Haga un click en la información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 –
revisión, abierto, básico; 2 – casos; 1 – opinión
GRATIS = Texto gratuito en algunos
países de la región iberoamericana (algunos artículos requieren ir a la tabla
de contenidos del número actual de la revista)
3 - Metabolic syndrome in outpatients receiving antipsychotic therapy in
routine clinical practice: A cross-sectional assessment of a primary health
care database
Antoni Sicras-Mainar, Milagrosa Blanca-Tamayo, Javier Rejas-Gutiérrez and Ruth Navarro-Artieda
European Psychiatry. Volume 23, Issue 2, March 2008, Pages 100-108
3 -
A Naturalistic Multicenter Trial of a 12-Week Weight Management Program for
Overweight and Obese Patients With Schizophrenia or
Schizoaffective Disorder
Seung Jae Lee, Eun
Ju Choi, and Jun Soo Kwon
J Clin Psychiatry February
27, 2008: e1-e8
5 -
Effects of Levetiracetam on Tardive
Dyskinesia: A Randomized, Double-Blind,
Placebo-Controlled Study
Scott W. Woods, John R. Saksa,
C. Bruce Baker, Shuki J. Cohen, and Cenk Tek
J Clin Psychiatry February
27, 2008: e1-e9
3! -
Recurrent
Dysregulation of Body Temperature During
Antipsychotic Pharmacotherapy
Stefan
Löffler, Peter Danos, Thomas B. Schillen,
Ansgar
Klimke
GRATIS 3 -
The schizotypal personality disorder: Historical
origins and current status
A. Laguerre,
M. Leboyer, F. Schürhoff
L’Encephale.
Vol 34 - N° 1 - Janvier 2008;p. 17 - 22
GRATIS 3! - Mortality among chronic schizophrenic patients: A
prospective 14-year follow-up study of 150 schizophrenic patients
G. Loas, A. Azi,
C. Noisette and V. Yon
L’Encephale.
Vol 34 - N° 1 - Janvier 2008;
p. 54 - 60
GRATIS 3 - Present data and treatment schedule of aripiprazole
in the treatment of schizophrenia
F. Limosin, J.M. Azorin, M.O. Krebs,
B. Millet, J. Glikman, V. Camus, M.A. Crocq, J. Costentin and J. Daléry
L'Encéphale.
Volume 34,
Issue 1, January 2008, Pages 82-92
GRATIS 3 - Comparative evaluation of clinical practice guidelines for the treatment
of schizophrenia
D.
Delessert, V. Pomini, F. Grasset and P. Baumann
L'Encéphale.
Volume 34,
Issue 1, January 2008, Pages 93-100
3 - Depression in schizophrenia: Comparison of first- and second-generation
antipsychotic drugs
Massimo
C. Mauri, Donatella Moliterno, Matteo Rossattini and Alessandro Colasanti
Schizophrenia Research. Volume 99, Issues 1-3, February 2008, Pages 7-12
4! - Weight gain induced by haloperidol, risperidone
and olanzapine after 1 year: Findings of a
randomized clinical trial in a drug-naïve population
Rocio
Perez-Iglesias, Benedicto Crespo-Facorro,
Obdulia Martinez-Garcia, Maria L. Ramirez-Bonilla,
Mario Alvarez-Jimenez, Jose M. Pelayo-Teran, Maria T.
Garcia-Unzueta, Jose A. Amado and Jose L. Vazquez-Barquero
Schizophrenia Research. Volume 99, Issues 1-3, February 2008, Pages 13-22
3 - Associations between early development and outcome in schizophrenia — A
35-year follow-up of the
Erika
Jääskeläinen, Jouko Miettunen, Juha Veijola, John J. McGrath, Graham K. Murray, Peter B. Jones
and Matti Isohanni
Schizophrenia Research. Volume 99, Issues 1-3, February 2008, Pages 29-37
3 - Meta-regression analysis using latitude as moderator of paternal age
related schizophrenia risk: High ambient temperature induced de novo mutations
or is it related to the cold?
Jackie
Y.W. Cheng, John S.N. Ko,
Ronald Y.L. Chen and Emil M.L. Ng
Schizophrenia Research. Volume 99, Issues 1-3, February 2008, Pages 71-76
3 - Cognitive deficits in early-onset schizophrenia spectrum patients and their
non-psychotic siblings: A comparison with ADHD
M.J.
Groom, G.M. Jackson, T.G. Calton, H.K. Andrews, A.T.
Bates, P.F. Liddle and C. Hollis
Schizophrenia Research. Volume 99, Issues 1-3, February 2008, Pages 85-95
3 - Impaired theory of mind in first-episode schizophrenia: comparison with
community, university and depressed controls
Jonathan
W.L. Kettle, Laurie O'Brien-Simpson and Nicholas B. Allen
Schizophrenia Research. Volume 99, Issues 1-3, February 2008, Pages 96-102
3 - Deficit of theory of mind in individuals at ultra-high-risk for
schizophrenia
Yu
Sun Chung, Do-Hyung Kang, Na Young Shin, So Young Yoo and Jun Soo Kwon
Schizophrenia Research. Volume 99, Issues 1-3, February 2008, Pages 111-118
3 - Are schizophrenia and schizoaffective disorder neuropsychologically
distinguishable?
R.
Walter Heinrichs, Narmeen Ammari, Stephanie McDermid Vaz and Ashley A. Miles
Schizophrenia Research. Volume 99, Issues 1-3, February 2008, Pages 149-154
3! -
Hyponatremia in Psychiatric Patients: Update on
Evaluation and Management
Arthur J. Siegel
Harvard Review of
Psychiatry, Volume 16, Issue 1 January 2008, pages 13 - 24
5 -
Time to Discontinuation of Depot and Oral First-Generation Antipsychotics in
the Usual Care of Schizophrenia
Baojin Zhu, Haya Ascher-Svanum, Lizheng Shi, Douglas Faries,
William Montgomery, and Stephen R. Marder
Psychiatr
Serv 59:315-317, March 2008
3! -
Chlorpromazine attenuates pancreatic beta–cell function and mass through IRS2
degradation, while exercise partially reverses the attenuation
Journal of Psychopharmacology. First published on February 28, 2008
3 -
Change in sexual dysfunction with aripiprazole: a
switching or add–on study
Amna Mir, Kuppuswami
Shivakumar, Richard J. Williamson, Victoria
McAllister, Veronica O'Keane, and Katherine J Aitchison
Journal of Psychopharmacology. First published on February 28, 2008
3 -
Who responds to aripiprazole in clinical practice? An
observational study of combination versus monotherapy
Polash Shajahan,
Alison MacRae, Muhammad Bashir,
and Mark Taylor
Journal of Psychopharmacology. First published on February 28, 2008
3! -
Pharmacokinetics and time–course of D2 receptor occupancy induced by
atypical antipsychotics in stabilized schizophrenic patients
Ana M. Catafau,
Maria M. Penengo, Gianluca Nucci, Santiago Bullich, Illuminada Corripio, Eduard Parellada, Carles García–Ribera, Roberto Gomeni,
and Emilio Merlo–Pich
Journal of Psychopharmacology. First published on February 28, 2008
3 -
Endogenous cannabinoids in patients with
schizophrenia and substance use disorder during quetiapine
therapy
Stephane Potvin,
Edouard Kouassi, Olivier Lipp, Roch–Hugo Bouchard,
Marc–Andre Roy, Marie–France Demers, Alain Gendron,
Giuseppe Astarita, Daniele Piomelli,
and Emmanuel Stip
Journal of Psychopharmacology. First published on February 28, 2008
3 -
Long–acting risperidone improves negative symptoms in
stable psychotic patients
Vivienne
A. Curtis, K. Katsafouros, H-J. Möller, Rossella Medori, and E
Sacchetti
Journal of Psychopharmacology. First published on February 28, 2008
3 - Asenapine: a novel psychopharmacologicagent with a unique human receptor
signature
Mohammed Shahid, Glenn B. Walker, Stevin H. Zorn, and Erik H. F.
Wong
Journal of
Psychopharmacology. First published on February 28, 2008
3 -
Vardenafil in the Treatment of Erectile Dysfunction
in Outpatients With Chronic Schizophrenia: A
Flexible-Dose, Open-Label Study
Charalampos I. Mitsonis,
Panagiotis A. Mitropoulos, Nikolaos
P. Dimopoulos, Evangelia G.
Kararizou, Vasiliki V. Psarra, Fivos E. Tsakiris, and Maria-Nefeli E. Katsanou
J Clin Psychiatry 2008;69:206-212
3 -
Comparing the Use and Discontinuation of Antipsychotics in Clinical Practice:
An Observational Study
Mark Taylor, Polash
Shajahan, and Stephen M. Lawrie
J Clin Psychiatry 2008;69:240-245
5 -
A Randomized, Double-Blind Comparison of Clozapine
and High-Dose Olanzapine in Treatment-Resistant
Patients With Schizophrenia
Herbert Y. Meltzer, William V. Bobo, Ajanta Roy, Karu Jayathilake, Yuejin Chen, Aygun Ertugrul, A. Elif Anil Yagcioglu, and Joyce G.
Small
J Clin Psychiatry 2008;69:274-285
5 -
A Review of Sensitivity and Tolerability of Antipsychotics in Patients With Bipolar Disorder or Schizophrenia: Focus on Somnolence
Keming Gao,
Stephen J. Ganocy, Prashant
Gajwani, David J. Muzina,
David E. Kemp, and Joseph R. Calabrese
J Clin Psychiatry 2008;69:302-309
3< - Contribution of perospirone
and risperidone to reduce delirium in senile patients
Michikazu USHIJIMA, Shin YOKOYAMA, Eiko SUGIYAMA, Naoji AMANO
Psychogeriatrics
2008; 8 (1), 4–7
3! - Protective effects of olanzapine and haloperidol
on serum withdrawal-induced apoptosis in SH-SY5Y cells
5 - A placebo controlled study of the propentofylline
added to risperidone in chronic schizophrenia
Samarand Salimi, Akbar Fotouhi, Abolfazl Ghoreishi, Mohammad-Kamran Derakhshan, Mohammad-Reza Khodaie-Ardakani, Mohammad-Reza Mohammadi,
Ahmad-Ali Noorbala, Seyed-Ali
Ahmadi-Abhari, Mohammad Hajiazim,
Seyed-Hesameddin Abbasi and
Shahin Akhondzadeh
3 - Evaluation of subjective treatment satisfaction with antipsychotics in
schizophrenia patients
Midori
Fujikawa, Takashi Togo, Asuka
Yoshimi, Junichi Fujita, Munetaka Nomoto,
Atsushi Kamijo, Toru Amagai,
Hirotake Uchikado, Omi Katsuse, Hideki Hosojima,
Yoshihisa Sakura, Ryo Furusho, Akira Suda, Takayuki Yamaguchi, Taketo Hori, Ayuko
Kamada, Taizo Kondo, Michitomo Ito, Toshinari Odawara and Yoshio Hirayasu
3< - Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: An open-label study
Tsuyoshi
Miyaoka, Motohide Furuya, Hideaki Yasuda, Maiko Hayashida,
Akira Nishida, Takuji Inagaki and Jun Horiguchi
5 -
Metformin Addition Attenuates Olanzapine-Induced
Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind,
Placebo-Controlled Study
Ren-Rong Wu, Jing-Ping
Zhao, Xiao-Feng Guo, Yi-Qun He, Mao-Sheng Fang, Wen-Bin Guo, Jin-Dong Chen, and
Le-Hua Li
Am J Psychiatry 2008; 165:352-358
3 - Pharmacological causes of hyperprolactinemia
Daria La Torre, Alberto
Falorni
Therapeutics and Clinical Risk Management. On Line Early. March 2008
3 - Interleukin-12 plasma levels in drug-naïve patients with a first episode
of psychosis: Effects of antipsychotic drugs
Benedicto Crespo-Facorro, Eugenio Carrasco-Marín,
Rocío Pérez-Iglesias, José María Pelayo-Terán, Lorena
Fernandez-Prieto, Francisco Leyva-Cobián
and José Luis Vázquez-Barquero
Psychiatry Research. Volume 158, Issue 2, 15 March 2008, Pages 206-216
3 - EEG abnormalities and 3-year outcome in first episode
psychosis
R. Manchanda, R. Norman, A. Malla,
R. Harricharan, S. Northcott
Acta Psychiatrica Scandinavica 2008;
117 (4), 277–282
GRATIS 3! - Schizophrenia, “Just the Facts”: What we know in 2008 Part 1: Overview
Rajiv
Tandon, Matcheri S. Keshavan and Henry A. Nasrallah
Schizophrenia Research. Volume 100, Issues 1-3, March 2008, Pages 4-19
GRATIS 3! - World Psychiatric Association Pharmacopsychiatry
Section statement on comparative effectiveness of antipsychotics in the
treatment of schizophrenia
Rajiv
Tandon, R.H. Belmaker,
Wagner F. Gattaz, Juan J. Lopez-Ibor
Jr., Ahmed Okasha, Bruce Singh, Dan J. Stein,
Jean-Pierre Olie, W. Wolfang
Fleischhacker, Hans-Juergen
Moeller and for the Section of Pharmacopsychiatry,
World Psychiatric Association
Schizophrenia Research. Volume 100, Issues 1-3, March 2008, Pages 20-38
GRATIS 4! - The effectiveness of antipsychotic medications in patients who use or
avoid illicit substances: Results from the CATIE study
Marvin
S. Swartz, H. Ryan Wagner, Jeffrey W. Swanson, T. Scott Stroup, Joseph P. McEvoy, Fred Reimherr, Del D.
Miller, Mark McGee, Ahsan Khan, Jose M. Canive, Sonia M. Davis, John K. Hsiao, Jeffrey A. Lieberman
and for the CATIE Investigators
Schizophrenia Research. Volume 100, Issues 1-3, March 2008, Pages 39-52
GRATIS 3 - Impact of atypical antipsychotic therapy on leptin,
ghrelin, and adiponectin
Hua
Jin, Jonathan M. Meyer, Sunder Mudaliar and Dilip V. Jeste
Schizophrenia Research. Volume 100, Issues 1-3, March 2008, Pages 70-85
GRATIS 3! - An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients
Daniel
J. Abrams, Lijun Zheng, Kevin S. Choo, Jun J.
Yang, Wei Wei, Thomas J. Anchordoquy,
Nasser H. Zawia and Karen E. Stevens
Schizophrenia Research. Volume 100, Issues 1-3, March 2008, Pages 86-96
GRATIS 3! - Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment
Jiri Modestin,
Marianne Vogt Wehrli, Patrik Lukas Stephan and Puspa Agarwalla
Schizophrenia Research. Volume 100, Issues 1-3, March 2008, Pages 97-107
GRATIS 3! - Effects of acute metabolic stress on the dopaminergic
and pituitary–adrenal axis activity in patients with schizophrenia, their
unaffected siblings and controls
Jerome
Brunelin, Thierry d'Amato,
Jim van Os, Alain Cochet, Marie-Françoise Suaud-Chagny and Mohamed Saoud
Schizophrenia Research. Volume 100, Issues 1-3, March 2008, Pages 206-211
GRATIS 3! - Self-reported motivation to smoke in schizophrenia is related to
antipsychotic drug treatment
Alasdair
M. Barr, Ric M. Procyshyn,
Philip Hui, Joy L. Johnson and William G. Honer
Schizophrenia Research. Volume 100, Issues 1-3, March 2008, Pages 252-260
3 - Early nicotine withdrawal and transdermal
nicotine effects on neurocognitive performance in
schizophrenia
Christopher
G. AhnAllen, Paul G. Nestor, Martha E. Shenton, Robert W. McCarley and
Margaret A. Niznikiewicz
Schizophrenia Research. Volume 100, Issues 1-3, March 2008, Pages 261-269
3 - Depression during an acute episode of schizophrenia or schizophreniform
disorder and its impact on treatment response
Markus
Jäger, Michael Riedel, Max Schmauß,
Herbert Pfeiffer, Gerd Laux,
Dieter Naber, Wolfgang Gaebel,
Wolfgang Huff, Lutz G. Schmidt, Isabella Heuser,
Gerhard Buchkremer, Kai-Uwe
Kühn, Eckart Rüther, Paul Hoff, Markus Gastpar,
Ronald Bottlender, Anton Strauß
and Hans-Jürgen Möller
Psychiatry Research. Volume 158, Issue 3, 15 April 2008, Pages 297-305
3 - Attitudes toward medication in inpatients with schizophrenia: A cluster
analytic approach
Giovanni
Santone, Paola Rucci, Marco Lazzarotto Muratori, Andrea Monaci, Cristina
Ciarafoni and Gabriele Borsetti
Psychiatry Research. Volume 158, Issue 3, 15 April 2008, Pages 324-334
3 -
Increased cortical inhibition in persons
with schizophrenia treated with clozapine
Zafiris J Daskalakis,
Bruce K Christensen, Paul B Fitzgerald, Bertram Moller, Sarah I Fountain, Robert Chen
Journal of
Psychopharmacology, Vol. 22, No. 2, 203-209 (2008)
3 - Comparative
effects of olanzapine and ziprasidone
on hypophagia induced by enhanced histamine
neurotransmission in the rat
Davoodi, Nima; Kalinichev, Mikhail;
Behavioural
Pharmacology. 19(2):121-128, March 2008
3 -
Effects of antipsychotics and reference monoaminergic
ligands on marble burying behavior
in mice
Bruins Slot, Liesbeth A; Bardin, Laurent; Auclair, Agnes
L; Depoortere, Ronan; Newman-Tancredi,
Behavioural
Pharmacology. 19(2):145-152, March 2008
5 -
Orlistat in Clozapine- or Olanzapine-Treated Patients With
Overweight or Obesity: A 16-Week Randomized, Double-Blind, Placebo-Controlled
Trial
Grigori Joffe,
Pirjo Takala, Evgueni Tchoukhine, Helinä Hakko, Mirjam Raidma, Hanna Putkonen, Markku Eronen, and Pirkko Räsänen
J Clin Psychiatry March 11,
2008: e1-e6
3 -
Efficacy of Iloperidone in the Treatment of
Schizophrenia: Initial Phase 3 Studies
Potkin, Steven G; Litman,
Robert E; Torres, Rosarelis; Wolfgang, Curt D
Journal of Clinical
Psychopharmacology. 28(7) Suppl.
1:S4-S11, April 2008
3 -
Safety Profile of Iloperidone: A Pooled Analysis of
6-Week Acute-Phase Pivotal Trials
Weiden, Peter J; Cutler, Andrew J; Polymeropoulos,
Mihael H; Wolfgang, Curt D
Journal of Clinical
Psychopharmacology. 28(7) Suppl.
1:S12-S19, April 2008
5 -
Four-Week, Double-Blind, Placebo- and Ziprasidone-Controlled
Trial of Iloperidone in Patients With
Acute Exacerbations of Schizophrenia
Cutler, Andrew J; Kalali,
Amir H; Weiden, Peter J; Hamilton, Jennifer;
Wolfgang, Curt D
Journal of Clinical
Psychopharmacology. 28(7) Suppl.
1:S20-S28, April 2008
4 -
Long-Term Efficacy and Safety of Iloperidone: Results
From 3 Clinical Trials for the Treatment of
Schizophrenia
Kane, John M; Lauriello,
John; Laska, Eugene; Di Marino, Michael; Wolfgang,
Curt D
Journal of Clinical Psychopharmacology. 28(7) Suppl. 1:S29-S35, April 2008
3! - Dyslipidemia Independent of Body Mass in
Antipsychotic-Treated Patients Under Real-Life
Conditions
Birkenaes, Astrid B; Birkeland, Kare I; Engh, John A; Faerden, Ann; Jonsdottir, Halldora; Ringen, Petter Andreas; Friis, Svein; Opjordsmoen, Stein; Andreassen, Ole A
Journal of Clinical
Psychopharmacology. 28(2):132-137,
April 2008
2 - A
Preliminary Investigation of [alpha]-Lipoic Acid
Treatment of Antipsychotic Drug-Induced Weight Gain in Patients With Schizophrenia
Kim, Eosu; Park, Dong-Wha; Choi, Song-Hee; Kim, Jae-Jin; Cho, Hyun-Sang
Journal of Clinical Psychopharmacology. 28(2):138-146, April 2008
3 -
Long-Acting Injectable Risperidone
in the Treatment of Subjects With Recent-Onset
Psychosis: A Preliminary Study
Emsley, Robin; Medori, Rossella; Koen, Liezl; Oosthuizen, Petrus Paulus; Niehaus, Dana J.H; Rabinowitz,
Jonathan
Journal of Clinical Psychopharmacology. 28(2):210-213, April 2008
5 -
Obsessive-Compulsive Symptoms in a Randomized, Double-Blind Study With Olanzapine or Risperidone in
Young Patients With Early Psychosis
van Nimwegen, Lonneke; de Haan, Lieuwe; van
Beveren, Nico; Laan, Winfried; van den Brink, Wim; Linszen, Don
Journal
of Clinical Psychopharmacology. 28(2):214-218, April 2008
GRATIS 3 - Evaluation of patients on sertindole
treatment after failure of other antipsychotics: a retrospective analysis
Jean-Michel Azorin